Cocrystal Pharma Inc. (COCP)
Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
Moleculin Releases On-Demand KOL Webcast to Discuss Data from its Phase 1B/2 Study of Annamycin for the Treatment of Soft Tissue Sarcoma (STS) Lung Metastases (MB-107)
Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Annovis to Host Webinar and Live Q&A on June 24, 2025
Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium
Teladoc Health to Participate in Upcoming Investor Conference
Core Molding Technologies to Present and Host 1x1 Meetings at the 15th Annual East Coast IDEAS Investor Conference on June 11, 2025